UI

Earlier this year, the results of another UI phase 2 clinical trial in patients with glioblastoma, a deadly form of brain cancer, were published.

Cullen was also part of that trial along with his colleague Bryan Allen, MD, PhD, UI professor and head of radiation oncology.

Cullen, Allen, and their colleagues at UI Health Care have been researching the anti-cancer effect of high-dose, IV vitamin C for decades.

In addition to Cullen and Allen, the UI team also included cancer physicians and researchers from the Departments of Surgery, Radiation Oncology, Internal Medicine in the UI Carver College of Medicine, the UI College of Public Health, and the Medical College of Wisconsin in Milwaukee.

The findings, published in the November issue of Redox Biology, mark another success for high-dose, intravenous vitamin C, which has overcome many hurdles in the almost 20 years UI researchers have persevered to demonstrate its benefit for cancer patients.